Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functions of Circular RNA in Human Diseases and Illnesses. | Noncoding RNA | 2023 | 37489458 | PubTator, text mining | PubMed |
| m5C regulator-mediated methylation modification phenotypes characterized by distinct tumor microenvironment immune heterogenicity in colorectal cancer. | Sci Rep | 2023 | 37488178 | PubTator, text mining | PubMed |
| Lysosomes, curcumin, and anti-tumor effects: how are they linked? | Front Pharmacol | 2023 | 37484013 | PubTator, text mining | PubMed |
| Dimethyl fumarate-related immune and transcriptional signature is associated with clinical response in multiple sclerosis-treated patients. | Front Immunol | 2023 | 37483622 | PubTator, text mining | PubMed |
| HBV-associated DLBCL of poor prognosis: advance in pathogenesis, immunity and therapy. | Front Immunol | 2023 | 37483605 | PubTator, text mining | PubMed |
| Insight of a lipid metabolism prognostic model to identify immune landscape and potential target for retroperitoneal liposarcoma. | Front Immunol | 2023 | 37483592 | PubTator, text mining | PubMed |
| Novel target and treatment agents for natural killer/T-cell lymphoma. | J Hematol Oncol | 2023 | 37480137 | PubTator, text mining | PubMed |
| CDC42-A promising immune-related target in glioma. | Front Neurosci | 2023 | 37476838 | PubTator, text mining | PubMed |
| A five-collagen-based risk model in lung adenocarcinoma: prognostic significance and immune landscape. | Front Oncol | 2023 | 37476379 | PubTator, text mining | PubMed |
| Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial-mesenchymal Transition in Aggressive Variant Prostate Cancers. | Cancer Res Commun | 2023 | 37476073 | PubTator, text mining | PubMed |
| Malignancy and viral infections in Sub-Saharan Africa: A review. | Front Virol | 2023 | 37476029 | PubTator, text mining | PubMed |
| GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer. | J Hematol Oncol | 2023 | 37475048 | PubTator, text mining | PubMed |
| Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022). | J Transl Med | 2023 | 37475035 | PubTator, text mining | PubMed |
| TNF superfamily control of tissue remodeling and fibrosis. | Front Immunol | 2023 | 37465675 | PubTator, text mining | PubMed |
| Intratumoral immune triads are required for adoptive T cell therapy-mediated elimination of solid tumors. | bioRxiv | 2023 | 37461721 | PubTator, text mining | PubMed |
| Post-COVID cognitive dysfunction: current status and research recommendations for high risk population. | Lancet Reg Health West Pac | 2023 | 37457901 | PubTator, text mining | PubMed |
| Recent advances and future perspectives of CAR-T cell therapy in head and neck cancer. | Front Immunol | 2023 | 37457699 | PubTator, text mining | PubMed |
| Revisiting mechanisms of resistance to immunotherapies in metastatic clear-cell renal-cell carcinoma. | Cancer Drug Resist | 2023 | 37457132 | PubTator, text mining | PubMed |
| Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities. | Br J Cancer | 2023 | 37454231 | PubTator, text mining | PubMed |
| Adverse events of antibody-drug conjugates on the ocular surface in cancer therapy. | Clin Transl Oncol | 2023 | 37454027 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=31